Towards risk-adapted therapy for rhabdoid tumour subgroups

Lancet Oncol. 2015 May;16(5):486-8. doi: 10.1016/S1470-2045(15)70170-1. Epub 2015 Apr 14.

Authors

Lindsey M Hoffman¹, Maryam Fouladi²

Affiliations

¹ Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
² Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA. Electronic address: [email protected].

PMID: 25882984
DOI: 10.1016/S1470-2045(15)70170-1

No abstract available

Publication types

Comment

MeSH terms

Basic Helix-Loop-Helix Transcription Factors / biosynthesis*
Female
Genomics*
Humans
Male
Receptors, Notch / biosynthesis*
Rhabdoid Tumor / genetics*
Teratoma / genetics*

Substances

Basic Helix-Loop-Helix Transcription Factors
Receptors, Notch